Aug 05, 2008
Pharmacopeia Announces Further Reductions to Workforce
Jul 31, 2008
Pharmacopeia Announces Second Quarter 2008 Financial Results
Jul 30, 2008
Pharmacopeia to Present at the Canaccord Adams 28th Annual Global Growth Conference
Jul 29, 2008
Pharmacopeia Earns Milestone Payment from Wyeth
Jul 24, 2008
Pharmacopeia Advances Therapeutic Program with GlaxoSmithKline
Jul 23, 2008
Pharmacopeia to Present at the BMO Capital Markets 8th Annual Focus on Healthcare Conference
Jul 17, 2008
Pharmacopeia to Host Second Quarter 2008 Financial Results Webcast and Conference Call
Jun 04, 2008
Pharmacopeia and GlaxoSmithKline Collaboration Identifies a New Lead Compound
May 30, 2008
Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
May 07, 2008
Pharmacopeia Announces First Quarter 2008 Financial Results
Apr 23, 2008
Pharmacopeia to Host First Quarter 2008 Financial Results Webcast and Conference Call
Apr 10, 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Mar 20, 2008
Pharmacopeia to Present at the 15th Annual Future Leaders in the Biotech Industry Conference
Mar 18, 2008
Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
Mar 11, 2008
Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference
Mar 05, 2008
Pharmacopeia Collaboration with Celgene Corporation Advances Compound Into Phase 1 Clinical Development
Mar 03, 2008
Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
Feb 28, 2008
Pharmacopeia Announces Fourth Quarter and Year-End Financial Results 2007
Feb 28, 2008
Pharmacopeia Announces Management Team Changes
Feb 26, 2008
Pharmacopeia Completes Enrolment in Phase 2 Hypertension Study with PS433540 (DARA)
Feb 14, 2008
Pharmacopeia to Host Fourth Quarter and Year-End 2007 Financial Results Webcast and Conference Call
Feb 13, 2008
Pharmacopeia to Present at the Roth 20th Annual OC Growth Stock Conference
Feb 11, 2008
Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development
Feb 04, 2008
Pharmacopeia to Present at BIO CEO & Investor Conference 2008
